# Efficacy of SGLT Activators on Water Absorption

## How effective are sodium-glucose cotransport activators in improving water absorption?

Sodium-glucose cotransport activators effectively improve water absorption in both experimental models and human subjects, with amino acid-based and glucose-based formulations showing significant increases in water uptake rates.

## Abstract

Sodium‐glucose cotransport activators improve water absorption in both experimental models and human subjects. Many studies report that amino acid–based activators—most notably L‑alanine and leucine—increase water uptake, with one study noting a rise from 17.4 to 43.9 μL/min/g (p < 0.001). Glucose‐based formulations administered in carefully balanced oral rehydration solutions yield similarly positive results; for example, one report documented an increase of 98.6 ± 16 μL/min/g (p < 0.01), and glucose polymers increased absorption rates from 221–240 to 291–332 μL/min/g (p < 0.02 to p < 0.005). In addition, interventions such as stevia extract yielded a 1.8‐fold boost in SGLT1‐mediated glucose transport (p < 0.05), an effect linked to improved water uptake. In diarrheal or secretory models, these activators also lower net fluid secretion and reduce stool water content. Overall, the studies indicate that activators targeting the sodium‐glucose cotransport mechanism effectively enhance water absorption as measured by both quantitative fluid uptake and associated transporter activity.

## Methods

We analyzed 29 sources from an initial pool of 997, using 7 screening criteria. Each paper was reviewed for 5 key aspects that mattered most to the research question.

## Results

### Characteristics of Included Studies

- **Study design**:
  - 23 studies were animal experimental (including in vivo physiological models).
  - 6 studies were human intervention studies (including in vivo physiological and noninvasive designs).
- **Clinical condition and species**:
  - 12 studies used diarrhea models.
  - 7 studies used normal (healthy) animals or humans.
  - 3 studies used short bowel syndrome models.
- **Intervention type**:
  - 6 studies tested amino acids or protein hydrolysate.
  - 6 studies tested oral rehydration solution composition.
  - 3 studies tested hormones.
- **Primary outcome measures**:
  - 15 studies measured water and sodium absorption.
  - 10 studies measured SGLT1 or NHE3 activity or expression.

### Water Absorption Outcomes

- **Activators**: L-alanine, Epidermal Growth Factor, Dexamethasone, Glutamine, and Glucose.
- **Effect**: Increased water absorption reported in most studies, with significant results indicated (p < 0.01).

### Sodium Absorption Outcomes

- **Activator Types**: Amino acid-based activators and glucose or glucose analogs.
- **Effect Size**: Increased sodium absorption or transporter activity reported in most studies.

### Comparative Effectiveness of Different Activators

- **Amino acids:** Alanine/protein hydrolysate > glycine (no effect).
- **Carbohydrates:** Various formulations like optimal glucose:sodium ratio were superior.

### Context-Dependent Effects and Generalizability

- Most evidence is from animal models, which limits direct translation to human clinical settings.
- Hormonal and pharmacological modulation was noted to enhance or suppress SGLT1 activity.

## References
- Numerous studies cited that support the findings on sodium-glucose cotransport activators and their effects on water absorption.